Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
DoorDash Down Over 12%, on Pace for Largest Percent Decrease Since November 2025 -- Data Talk

DoorDash Down Over 12%, on Pace for Largest Percent Decrease Since November 2025 -- Data Talk

Dow JonesDow Jones2026/11/05 15:21

DoorDash Inc. (DASH) is currently at $173.49, down $25.1 or 12.64%

--Would be lowest close since Oct. 28, 2026, when it closed at $169.49

--On pace for largest percent decrease since Nov. 6, 2025, when it fell 17.45%

--Currently down four of the past seven days

--Down 23.40% year-to-date; on pace for worst year since 2022, when it fell 67.21%

--Down 38.42% from its all-time closing high of $281.74 on Oct. 6, 2025

--Down 11.69% from 52 weeks ago (Nov. 6, 2025), when it closed at $196.46

--Down 26.78% from its 52-week closing high of $236.93 on Aug. 26, 2026

--Up 18.34% from its 52-week closing low of $146.60 on March 27, 2026

--Traded as low as $171.49; lowest intraday level since Oct. 28, 2026, when it hit $166.84

--Down 13.65% at today's intraday low; largest intraday percent decrease since Nov. 6, 2025, when it fell as much as 18.20%

--Eighth worst performer in the S&P 500 today

--Eighth worst performer in the Nasdaq 100 today

All data as of 10:19:11 AM EST

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 05, 2026 10:21 ET (15:21 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny